Emergent BioSolutions Inc. — Director's Dealing 2011

Apr 20, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2011-04-18

Reporting Person: Intervac, L.L.C. (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-04-18	Common Stock	S	7000	$23.3146	Disposed	6136794	Direct

Footnotes

F1: This price is the weighted average sale price for the transaction reported on this line. The prices for this transaction range from $23.01 to $24.00. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F2: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2011.